95 related articles for article (PubMed ID: 11494543)
21. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
22. Daily interferon therapy for chronic hepatitis C: a report of a community practice experience.
Srinivas D; Mani H; Crumpler C; Van Thiel DH
Hepatogastroenterology; 2002; 49(46):1053-7. PubMed ID: 12143200
[TBL] [Abstract][Full Text] [Related]
23. Prospective study of interferon therapy for compensated cirrhotic patients with chronic hepatitis C by monitoring serum hepatitis C RNA.
Shiratori Y; Yokosuka O; Nakata R; Ihori M; Hirota K; Katamoto T; Unuma T; Okano K; Ikeda Y; Hirano M; Kawase T; Takano S; Matsumoto K; Ohashi Y; Omata M
Hepatology; 1999 May; 29(5):1573-80. PubMed ID: 10216145
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of twice-daily administration of interferon-beta for chronic hepatitis C.
Kakizaki S; Takagi H; Yamada T; Ichikawa T; Abe T; Sohara N; Kosone T; Kaneko M; Takezawa J; Takayama H; Nagamine T; Mori M
J Viral Hepat; 1999 Jul; 6(4):315-9. PubMed ID: 10607246
[TBL] [Abstract][Full Text] [Related]
25. Anti-viral actions and viral dynamics in the early phase of three different regimens of interferon treatment for chronic hepatitis C: differences between the twice-daily administration of interferon-beta treatment and the combination therapy with interferon-alpha plus ribavirin.
Nakajima H; Shimomura H; Iwasaki Y; Ikeda F; Umeoka F; Chengyu P; Taniguchi H; Ohnishi Y; Takagi SJ; Fujioka S; Shiratori Y
Acta Med Okayama; 2003 Oct; 57(5):217-25. PubMed ID: 14679399
[TBL] [Abstract][Full Text] [Related]
26. [Dynamics of serum HCV RNA levels during IFN therapy in patients with chronic hepatitis C for prediction of outcome of IFN therapy and beneficial dosing].
Iwabuchi S; Takatsuka K
Nihon Rinsho; 2001 Jul; 59(7):1363-8. PubMed ID: 11494552
[TBL] [Abstract][Full Text] [Related]
27. [Study for relapse cases of chronic hepatitis C treated with interferon (IFN) and approach to more successful re-treatment of IFN].
Iwabuchi S; Yoshida H; Fukui S
Nihon Rinsho; 1994 Jul; 52(7):1810-6. PubMed ID: 7521423
[TBL] [Abstract][Full Text] [Related]
28. [Examination in clinical course of HCV in interferon treatment].
Kumada H
Nihon Rinsho; 1994 Jul; 52(7):1832-5. PubMed ID: 7521426
[TBL] [Abstract][Full Text] [Related]
29. Different turnover rate of hepatitis C virus clearance by different treatment regimen using interferon-beta.
Shiratori Y; Perelson AS; Weinberger L; Imazeki F; Yokosuka O; Nakata R; Ihori M; Hirota K; Ono N; Kuroda H; Motojima T; Nishigaki M; Omata M
J Hepatol; 2000 Aug; 33(2):313-22. PubMed ID: 10952250
[TBL] [Abstract][Full Text] [Related]
30. [IFN combined cyclosporin A therapy].
Inoue K; Yoshiba M
Nihon Rinsho; 2001 Jul; 59(7):1326-30. PubMed ID: 11494546
[TBL] [Abstract][Full Text] [Related]
31. The efficacy of a herbal medicine (Mao-to) in combination with intravenous natural interferon-beta for patients with chronic hepatitis C, genotype 1b and high viral load: a pilot study.
Kainuma M; Ogata N; Kogure T; Kohta K; Hattori N; Mitsuma T; Terasawa K
Phytomedicine; 2002 Jul; 9(5):365-72. PubMed ID: 12222653
[TBL] [Abstract][Full Text] [Related]
32. Twice-daily administration of interferon-beta for chronic hepatitis C is not superior to a once-daily regimen.
Suzuki F; Chayama K; Tsubota A; Akuta N; Someya T; Kobayashi M; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kumada H
J Gastroenterol; 2001 Apr; 36(4):242-7. PubMed ID: 11324727
[TBL] [Abstract][Full Text] [Related]
33. Complete response to twice-a-day interferon-beta with standard interferon-alpha therapy in acute hepatitis C after a needle-stick.
Oketani M; Higashi T; Yamasaki N; Shinmyozu K; Osame M; Arima T
J Clin Gastroenterol; 1999 Jan; 28(1):49-51. PubMed ID: 9916668
[TBL] [Abstract][Full Text] [Related]
34. Zinc supplementation enhances the response to interferon therapy in patients with chronic hepatitis C.
Takagi H; Nagamine T; Abe T; Takayama H; Sato K; Otsuka T; Kakizaki S; Hashimoto Y; Matsumoto T; Kojima A; Takezawa J; Suzuki K; Sato S; Mori M
J Viral Hepat; 2001 Sep; 8(5):367-71. PubMed ID: 11555194
[TBL] [Abstract][Full Text] [Related]
35. Pretreatment symptoms and dosing regimen predict side-effects of interferon therapy for hepatitis C.
Cotler SJ; Wartelle CF; Larson AM; Gretch DR; Jensen DM; Carithers RL
J Viral Hepat; 2000 May; 7(3):211-7. PubMed ID: 10849263
[TBL] [Abstract][Full Text] [Related]
36. Rapid decrease of plasma HCV RNA in early phase of twice daily administration of 3 MU doses interferon-beta in patients with genotype 1b hepatitis C infection: a multicenter randomized study.
Izumi N; Kumada H; Hashimoto N; Harada H; Imawari M; Zeniya M; Toda G
Dig Dis Sci; 2001 Mar; 46(3):516-23. PubMed ID: 11318525
[TBL] [Abstract][Full Text] [Related]
37. How severe is chronic hepatitis with HCV genotype 1b? A study of 1,220 cases on the waiting list for antiviral therapy in Romania.
Pascu O; Gheorghe L; Voiculescu M; Ceausu E; Mateescu B
J Gastrointestin Liver Dis; 2011 Mar; 20(1):51-5. PubMed ID: 21451798
[TBL] [Abstract][Full Text] [Related]
38. Impact of virus clearance for the development of hemorrhagic stroke in chronic hepatitis C.
Arase Y; Kobayashi M; Kawamura Y; Suzuki F; Suzuki Y; Akuta N; Kobayashi M; Sezaki H; Saito S; Hosaka T; Ikeda K; Kumada H; Kobayashi T
J Med Virol; 2014 Jan; 86(1):169-75. PubMed ID: 24155199
[TBL] [Abstract][Full Text] [Related]
39. Ischemic colitis with type I interferons used in the treatment of hepatitis C and multiple sclerosis: an evaluation from the food and drug administration adverse event reporting system and review of the literature.
Salk A; Stobaugh DJ; Deepak P; Ehrenpreis ED
Ann Pharmacother; 2013 Apr; 47(4):537-42. PubMed ID: 23535814
[TBL] [Abstract][Full Text] [Related]
40. Influence of TT virus co-infection on IFN-beta therapy in patients with chronic hepatitis C.
Yamada T; Naitou H; Morita T
Kansenshogaku Zasshi; 2002 Sep; 76(9):747-53. PubMed ID: 12391678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
